nodes	percent_of_prediction	percent_of_DWPC	metapath
Isoprenaline—CYP1A1—Clobetasol propionate—psoriasis	0.267	0.494	CbGbCtD
Isoprenaline—CYP1A1—Methoxsalen—psoriasis	0.14	0.26	CbGbCtD
Isoprenaline—CYP1A1—Cholecalciferol—psoriasis	0.0928	0.172	CbGbCtD
Isoprenaline—CYP1A1—Dexamethasone—psoriasis	0.0401	0.0744	CbGbCtD
Isoprenaline—Bronchospasm—Beclomethasone—psoriasis	0.0022	0.0212	CcSEcCtD
Isoprenaline—Pallor—Mycophenolic acid—psoriasis	0.00176	0.0169	CcSEcCtD
Isoprenaline—Pulmonary oedema—Hydroxyurea—psoriasis	0.00155	0.0149	CcSEcCtD
Isoprenaline—Pallor—Mycophenolate mofetil—psoriasis	0.00139	0.0134	CcSEcCtD
Isoprenaline—Pulmonary oedema—Mycophenolic acid—psoriasis	0.0013	0.0125	CcSEcCtD
Isoprenaline—Arrhythmia—Methoxsalen—psoriasis	0.00125	0.0121	CcSEcCtD
Isoprenaline—Tension—Methoxsalen—psoriasis	0.0012	0.0115	CcSEcCtD
Isoprenaline—Nervousness—Methoxsalen—psoriasis	0.00119	0.0114	CcSEcCtD
Isoprenaline—Arrhythmia—Calcitriol—psoriasis	0.00112	0.0108	CcSEcCtD
Isoprenaline—Vertigo—Methoxsalen—psoriasis	0.0011	0.0106	CcSEcCtD
Isoprenaline—Flushing—Acitretin—psoriasis	0.00103	0.00994	CcSEcCtD
Isoprenaline—Pulmonary oedema—Mycophenolate mofetil—psoriasis	0.00102	0.00985	CcSEcCtD
Isoprenaline—Cardiac arrest—Mycophenolic acid—psoriasis	0.001	0.00968	CcSEcCtD
Isoprenaline—Pulmonary oedema—Prednisolone—psoriasis	0.000954	0.00919	CcSEcCtD
Isoprenaline—Tension—Acitretin—psoriasis	0.00095	0.00915	CcSEcCtD
Isoprenaline—Convulsion—Calcitriol—psoriasis	0.000943	0.00908	CcSEcCtD
Isoprenaline—Nervousness—Acitretin—psoriasis	0.00094	0.00906	CcSEcCtD
Isoprenaline—Hypertension—Calcitriol—psoriasis	0.000939	0.00905	CcSEcCtD
Isoprenaline—Pulmonary oedema—Hydrocortisone—psoriasis	0.000932	0.00897	CcSEcCtD
Isoprenaline—Hypotension—Methoxsalen—psoriasis	0.000931	0.00897	CcSEcCtD
Isoprenaline—Vision blurred—Acitretin—psoriasis	0.000912	0.00879	CcSEcCtD
Isoprenaline—Vision blurred—Fluocinolone Acetonide—psoriasis	0.00091	0.00876	CcSEcCtD
Isoprenaline—Insomnia—Methoxsalen—psoriasis	0.000901	0.00868	CcSEcCtD
Isoprenaline—Angina pectoris—Mycophenolic acid—psoriasis	0.00089	0.00857	CcSEcCtD
Isoprenaline—Pulmonary oedema—Triamcinolone—psoriasis	0.000877	0.00845	CcSEcCtD
Isoprenaline—Headache—Clobetasol propionate—psoriasis	0.000877	0.00844	CcSEcCtD
Isoprenaline—Vertigo—Fluocinolone Acetonide—psoriasis	0.000867	0.00835	CcSEcCtD
Isoprenaline—Dizziness—Beclomethasone—psoriasis	0.000842	0.00811	CcSEcCtD
Isoprenaline—Dizziness—Fluocinonide—psoriasis	0.000835	0.00804	CcSEcCtD
Isoprenaline—Insomnia—Calcitriol—psoriasis	0.000803	0.00774	CcSEcCtD
Isoprenaline—Headache—Beclomethasone—psoriasis	0.000798	0.00769	CcSEcCtD
Isoprenaline—Pulmonary oedema—Dexamethasone—psoriasis	0.000796	0.00767	CcSEcCtD
Isoprenaline—Pulmonary oedema—Betamethasone—psoriasis	0.000796	0.00767	CcSEcCtD
Isoprenaline—Cardiac arrest—Mycophenolate mofetil—psoriasis	0.000793	0.00764	CcSEcCtD
Isoprenaline—Headache—Fluocinonide—psoriasis	0.000791	0.00762	CcSEcCtD
Isoprenaline—Sweating—Mycophenolic acid—psoriasis	0.000781	0.00752	CcSEcCtD
Isoprenaline—Hyperhidrosis—Acitretin—psoriasis	0.000764	0.00736	CcSEcCtD
Isoprenaline—Nausea—Beclomethasone—psoriasis	0.000757	0.00729	CcSEcCtD
Isoprenaline—Cardiac arrest—Prednisolone—psoriasis	0.00074	0.00713	CcSEcCtD
Isoprenaline—Bronchospasm—Cyclosporine—psoriasis	0.000727	0.007	CcSEcCtD
Isoprenaline—Cardiac arrest—Hydrocortisone—psoriasis	0.000722	0.00696	CcSEcCtD
Isoprenaline—Insomnia—Acitretin—psoriasis	0.000714	0.00688	CcSEcCtD
Isoprenaline—Angina pectoris—Mycophenolate mofetil—psoriasis	0.000702	0.00676	CcSEcCtD
Isoprenaline—Pulmonary oedema—Prednisone—psoriasis	0.000693	0.00668	CcSEcCtD
Isoprenaline—Cardiac arrest—Triamcinolone—psoriasis	0.00068	0.00655	CcSEcCtD
Isoprenaline—Dizziness—Methoxsalen—psoriasis	0.000659	0.00635	CcSEcCtD
Isoprenaline—Convulsion—Hydroxyurea—psoriasis	0.000658	0.00634	CcSEcCtD
Isoprenaline—Arrhythmia—Mycophenolic acid—psoriasis	0.000653	0.00629	CcSEcCtD
Isoprenaline—Asthenia—Calcitriol—psoriasis	0.000637	0.00614	CcSEcCtD
Isoprenaline—Tension—Mycophenolic acid—psoriasis	0.000625	0.00602	CcSEcCtD
Isoprenaline—Headache—Methoxsalen—psoriasis	0.000624	0.00601	CcSEcCtD
Isoprenaline—Nervousness—Mycophenolic acid—psoriasis	0.000618	0.00595	CcSEcCtD
Isoprenaline—Cardiac arrest—Dexamethasone—psoriasis	0.000617	0.00595	CcSEcCtD
Isoprenaline—Cardiac arrest—Betamethasone—psoriasis	0.000617	0.00595	CcSEcCtD
Isoprenaline—Sweating—Mycophenolate mofetil—psoriasis	0.000616	0.00594	CcSEcCtD
Isoprenaline—Vision blurred—Mycophenolic acid—psoriasis	0.0006	0.00578	CcSEcCtD
Isoprenaline—Tremor—Mycophenolic acid—psoriasis	0.000596	0.00574	CcSEcCtD
Isoprenaline—Nausea—Methoxsalen—psoriasis	0.000592	0.0057	CcSEcCtD
Isoprenaline—Pulmonary oedema—Methotrexate—psoriasis	0.000579	0.00558	CcSEcCtD
Isoprenaline—Vertigo—Mycophenolic acid—psoriasis	0.000572	0.00551	CcSEcCtD
Isoprenaline—Asthenia—Acitretin—psoriasis	0.000567	0.00546	CcSEcCtD
Isoprenaline—Palpitations—Mycophenolic acid—psoriasis	0.000562	0.00542	CcSEcCtD
Isoprenaline—Headache—Calcitriol—psoriasis	0.000556	0.00536	CcSEcCtD
Isoprenaline—Dyspnoea—Hydroxyurea—psoriasis	0.000553	0.00533	CcSEcCtD
Isoprenaline—Convulsion—Mycophenolic acid—psoriasis	0.000551	0.00531	CcSEcCtD
Isoprenaline—Hypertension—Mycophenolic acid—psoriasis	0.000549	0.00529	CcSEcCtD
Isoprenaline—Flushing—Cyclosporine—psoriasis	0.000549	0.00529	CcSEcCtD
Isoprenaline—Cardiac arrest—Prednisone—psoriasis	0.000538	0.00518	CcSEcCtD
Isoprenaline—Arrhythmia—Cyclosporine—psoriasis	0.000528	0.00509	CcSEcCtD
Isoprenaline—Nausea—Calcitriol—psoriasis	0.000527	0.00508	CcSEcCtD
Isoprenaline—Dizziness—Acitretin—psoriasis	0.000522	0.00503	CcSEcCtD
Isoprenaline—Dizziness—Fluocinolone Acetonide—psoriasis	0.000521	0.00502	CcSEcCtD
Isoprenaline—Arrhythmia—Mycophenolate mofetil—psoriasis	0.000515	0.00496	CcSEcCtD
Isoprenaline—Tachycardia—Mycophenolic acid—psoriasis	0.000507	0.00488	CcSEcCtD
Isoprenaline—Tension—Cyclosporine—psoriasis	0.000505	0.00487	CcSEcCtD
Isoprenaline—Hyperhidrosis—Mycophenolic acid—psoriasis	0.000502	0.00484	CcSEcCtD
Isoprenaline—Nervousness—Cyclosporine—psoriasis	0.0005	0.00482	CcSEcCtD
Isoprenaline—Headache—Acitretin—psoriasis	0.000495	0.00477	CcSEcCtD
Isoprenaline—Headache—Fluocinolone Acetonide—psoriasis	0.000493	0.00475	CcSEcCtD
Isoprenaline—Tension—Mycophenolate mofetil—psoriasis	0.000493	0.00475	CcSEcCtD
Isoprenaline—Nervousness—Mycophenolate mofetil—psoriasis	0.000488	0.0047	CcSEcCtD
Isoprenaline—Hypotension—Mycophenolic acid—psoriasis	0.000485	0.00468	CcSEcCtD
Isoprenaline—Vision blurred—Cyclosporine—psoriasis	0.000485	0.00467	CcSEcCtD
Isoprenaline—Tremor—Cyclosporine—psoriasis	0.000482	0.00465	CcSEcCtD
Isoprenaline—Arrhythmia—Prednisolone—psoriasis	0.000481	0.00463	CcSEcCtD
Isoprenaline—Tremor—Mycophenolate mofetil—psoriasis	0.000471	0.00453	CcSEcCtD
Isoprenaline—Insomnia—Mycophenolic acid—psoriasis	0.00047	0.00453	CcSEcCtD
Isoprenaline—Arrhythmia—Hydrocortisone—psoriasis	0.00047	0.00452	CcSEcCtD
Isoprenaline—Nausea—Acitretin—psoriasis	0.000469	0.00452	CcSEcCtD
Isoprenaline—Nausea—Fluocinolone Acetonide—psoriasis	0.000468	0.00451	CcSEcCtD
Isoprenaline—Dyspnoea—Mycophenolic acid—psoriasis	0.000463	0.00446	CcSEcCtD
Isoprenaline—Vertigo—Cyclosporine—psoriasis	0.000463	0.00446	CcSEcCtD
Isoprenaline—Vertigo—Mycophenolate mofetil—psoriasis	0.000451	0.00435	CcSEcCtD
Isoprenaline—Convulsion—Cyclosporine—psoriasis	0.000446	0.0043	CcSEcCtD
Isoprenaline—Asthenia—Hydroxyurea—psoriasis	0.000445	0.00429	CcSEcCtD
Isoprenaline—Hypertension—Cyclosporine—psoriasis	0.000445	0.00428	CcSEcCtD
Isoprenaline—Palpitations—Mycophenolate mofetil—psoriasis	0.000444	0.00428	CcSEcCtD
Isoprenaline—Arrhythmia—Triamcinolone—psoriasis	0.000442	0.00426	CcSEcCtD
Isoprenaline—Vision blurred—Prednisolone—psoriasis	0.000442	0.00425	CcSEcCtD
Isoprenaline—Convulsion—Mycophenolate mofetil—psoriasis	0.000435	0.00419	CcSEcCtD
Isoprenaline—Hypertension—Mycophenolate mofetil—psoriasis	0.000434	0.00418	CcSEcCtD
Isoprenaline—Vertigo—Prednisolone—psoriasis	0.000421	0.00405	CcSEcCtD
Isoprenaline—Vertigo—Hydrocortisone—psoriasis	0.000411	0.00396	CcSEcCtD
Isoprenaline—Dizziness—Hydroxyurea—psoriasis	0.00041	0.00395	CcSEcCtD
Isoprenaline—Hyperhidrosis—Cyclosporine—psoriasis	0.000406	0.00391	CcSEcCtD
Isoprenaline—Convulsion—Prednisolone—psoriasis	0.000406	0.00391	CcSEcCtD
Isoprenaline—Hypertension—Prednisolone—psoriasis	0.000404	0.0039	CcSEcCtD
Isoprenaline—Arrhythmia—Dexamethasone—psoriasis	0.000401	0.00386	CcSEcCtD
Isoprenaline—Arrhythmia—Betamethasone—psoriasis	0.000401	0.00386	CcSEcCtD
Isoprenaline—Tachycardia—Mycophenolate mofetil—psoriasis	0.0004	0.00385	CcSEcCtD
Isoprenaline—Convulsion—Hydrocortisone—psoriasis	0.000396	0.00382	CcSEcCtD
Isoprenaline—Hyperhidrosis—Mycophenolate mofetil—psoriasis	0.000396	0.00382	CcSEcCtD
Isoprenaline—Hypertension—Hydrocortisone—psoriasis	0.000395	0.00381	CcSEcCtD
Isoprenaline—Headache—Hydroxyurea—psoriasis	0.000389	0.00374	CcSEcCtD
Isoprenaline—Vertigo—Triamcinolone—psoriasis	0.000387	0.00373	CcSEcCtD
Isoprenaline—Hypotension—Mycophenolate mofetil—psoriasis	0.000383	0.00369	CcSEcCtD
Isoprenaline—Insomnia—Cyclosporine—psoriasis	0.00038	0.00366	CcSEcCtD
Isoprenaline—Dyspnoea—Cyclosporine—psoriasis	0.000375	0.00361	CcSEcCtD
Isoprenaline—Convulsion—Triamcinolone—psoriasis	0.000373	0.0036	CcSEcCtD
Isoprenaline—Tachycardia—Prednisolone—psoriasis	0.000373	0.00359	CcSEcCtD
Isoprenaline—Asthenia—Mycophenolic acid—psoriasis	0.000373	0.00359	CcSEcCtD
Isoprenaline—Hypertension—Triamcinolone—psoriasis	0.000372	0.00358	CcSEcCtD
Isoprenaline—Insomnia—Mycophenolate mofetil—psoriasis	0.000371	0.00357	CcSEcCtD
Isoprenaline—Hyperhidrosis—Prednisolone—psoriasis	0.00037	0.00356	CcSEcCtD
Isoprenaline—Nausea—Hydroxyurea—psoriasis	0.000368	0.00355	CcSEcCtD
Isoprenaline—Dyspnoea—Mycophenolate mofetil—psoriasis	0.000365	0.00352	CcSEcCtD
Isoprenaline—Tachycardia—Hydrocortisone—psoriasis	0.000364	0.00351	CcSEcCtD
Isoprenaline—Flushing—Prednisone—psoriasis	0.000363	0.0035	CcSEcCtD
Isoprenaline—Hyperhidrosis—Hydrocortisone—psoriasis	0.000361	0.00348	CcSEcCtD
Isoprenaline—Vertigo—Dexamethasone—psoriasis	0.000351	0.00338	CcSEcCtD
Isoprenaline—Vertigo—Betamethasone—psoriasis	0.000351	0.00338	CcSEcCtD
Isoprenaline—Arrhythmia—Prednisone—psoriasis	0.000349	0.00337	CcSEcCtD
Isoprenaline—Sweating—Methotrexate—psoriasis	0.000349	0.00336	CcSEcCtD
Isoprenaline—Hypotension—Hydrocortisone—psoriasis	0.000349	0.00336	CcSEcCtD
Isoprenaline—Insomnia—Prednisolone—psoriasis	0.000346	0.00333	CcSEcCtD
Isoprenaline—Dizziness—Mycophenolic acid—psoriasis	0.000343	0.00331	CcSEcCtD
Isoprenaline—Tachycardia—Triamcinolone—psoriasis	0.000343	0.00331	CcSEcCtD
Isoprenaline—Hyperhidrosis—Triamcinolone—psoriasis	0.00034	0.00327	CcSEcCtD
Isoprenaline—Convulsion—Dexamethasone—psoriasis	0.000339	0.00326	CcSEcCtD
Isoprenaline—Convulsion—Betamethasone—psoriasis	0.000339	0.00326	CcSEcCtD
Isoprenaline—Insomnia—Hydrocortisone—psoriasis	0.000338	0.00325	CcSEcCtD
Isoprenaline—Hypertension—Betamethasone—psoriasis	0.000338	0.00325	CcSEcCtD
Isoprenaline—Hypertension—Dexamethasone—psoriasis	0.000338	0.00325	CcSEcCtD
Isoprenaline—Headache—Mycophenolic acid—psoriasis	0.000325	0.00313	CcSEcCtD
Isoprenaline—Vision blurred—Prednisone—psoriasis	0.000321	0.00309	CcSEcCtD
Isoprenaline—Insomnia—Triamcinolone—psoriasis	0.000318	0.00306	CcSEcCtD
Isoprenaline—Dyspnoea—Triamcinolone—psoriasis	0.000313	0.00302	CcSEcCtD
Isoprenaline—Tachycardia—Dexamethasone—psoriasis	0.000311	0.003	CcSEcCtD
Isoprenaline—Tachycardia—Betamethasone—psoriasis	0.000311	0.003	CcSEcCtD
Isoprenaline—Nausea—Mycophenolic acid—psoriasis	0.000309	0.00297	CcSEcCtD
Isoprenaline—Hyperhidrosis—Dexamethasone—psoriasis	0.000308	0.00297	CcSEcCtD
Isoprenaline—Hyperhidrosis—Betamethasone—psoriasis	0.000308	0.00297	CcSEcCtD
Isoprenaline—Vertigo—Prednisone—psoriasis	0.000306	0.00295	CcSEcCtD
Isoprenaline—Asthenia—Cyclosporine—psoriasis	0.000301	0.0029	CcSEcCtD
Isoprenaline—Hypotension—Dexamethasone—psoriasis	0.000298	0.00287	CcSEcCtD
Isoprenaline—Hypotension—Betamethasone—psoriasis	0.000298	0.00287	CcSEcCtD
Isoprenaline—Convulsion—Prednisone—psoriasis	0.000295	0.00284	CcSEcCtD
Isoprenaline—Asthenia—Mycophenolate mofetil—psoriasis	0.000294	0.00283	CcSEcCtD
Isoprenaline—Hypertension—Prednisone—psoriasis	0.000294	0.00283	CcSEcCtD
Isoprenaline—Insomnia—Dexamethasone—psoriasis	0.000289	0.00278	CcSEcCtD
Isoprenaline—Insomnia—Betamethasone—psoriasis	0.000289	0.00278	CcSEcCtD
Isoprenaline—Dizziness—Cyclosporine—psoriasis	0.000278	0.00268	CcSEcCtD
Isoprenaline—Tachycardia—Prednisone—psoriasis	0.000271	0.00261	CcSEcCtD
Isoprenaline—Dizziness—Mycophenolate mofetil—psoriasis	0.000271	0.00261	CcSEcCtD
Isoprenaline—Hyperhidrosis—Prednisone—psoriasis	0.000269	0.00259	CcSEcCtD
Isoprenaline—Vision blurred—Methotrexate—psoriasis	0.000268	0.00258	CcSEcCtD
Isoprenaline—Asthenia—Hydrocortisone—psoriasis	0.000268	0.00258	CcSEcCtD
Isoprenaline—Headache—Cyclosporine—psoriasis	0.000263	0.00254	CcSEcCtD
Isoprenaline—Headache—Mycophenolate mofetil—psoriasis	0.000257	0.00247	CcSEcCtD
Isoprenaline—Vertigo—Methotrexate—psoriasis	0.000256	0.00246	CcSEcCtD
Isoprenaline—Dizziness—Prednisolone—psoriasis	0.000253	0.00244	CcSEcCtD
Isoprenaline—Asthenia—Triamcinolone—psoriasis	0.000252	0.00243	CcSEcCtD
Isoprenaline—Insomnia—Prednisone—psoriasis	0.000251	0.00242	CcSEcCtD
Isoprenaline—Nausea—Cyclosporine—psoriasis	0.00025	0.0024	CcSEcCtD
Isoprenaline—Dizziness—Hydrocortisone—psoriasis	0.000247	0.00238	CcSEcCtD
Isoprenaline—Convulsion—Methotrexate—psoriasis	0.000247	0.00237	CcSEcCtD
Isoprenaline—Nausea—Mycophenolate mofetil—psoriasis	0.000243	0.00235	CcSEcCtD
Isoprenaline—Headache—Prednisolone—psoriasis	0.00024	0.00231	CcSEcCtD
Isoprenaline—Headache—Hydrocortisone—psoriasis	0.000234	0.00225	CcSEcCtD
Isoprenaline—Dizziness—Triamcinolone—psoriasis	0.000233	0.00224	CcSEcCtD
Isoprenaline—Asthenia—Betamethasone—psoriasis	0.000229	0.00221	CcSEcCtD
Isoprenaline—Asthenia—Dexamethasone—psoriasis	0.000229	0.00221	CcSEcCtD
Isoprenaline—Nausea—Prednisolone—psoriasis	0.000227	0.00219	CcSEcCtD
Isoprenaline—Hyperhidrosis—Methotrexate—psoriasis	0.000224	0.00216	CcSEcCtD
Isoprenaline—Nausea—Hydrocortisone—psoriasis	0.000222	0.00214	CcSEcCtD
Isoprenaline—Headache—Triamcinolone—psoriasis	0.00022	0.00212	CcSEcCtD
Isoprenaline—Hypotension—Methotrexate—psoriasis	0.000217	0.00209	CcSEcCtD
Isoprenaline—Dizziness—Dexamethasone—psoriasis	0.000211	0.00203	CcSEcCtD
Isoprenaline—Dizziness—Betamethasone—psoriasis	0.000211	0.00203	CcSEcCtD
Isoprenaline—Insomnia—Methotrexate—psoriasis	0.00021	0.00202	CcSEcCtD
Isoprenaline—Nausea—Triamcinolone—psoriasis	0.000209	0.00201	CcSEcCtD
Isoprenaline—Dyspnoea—Methotrexate—psoriasis	0.000207	0.00199	CcSEcCtD
Isoprenaline—Headache—Dexamethasone—psoriasis	0.0002	0.00193	CcSEcCtD
Isoprenaline—Headache—Betamethasone—psoriasis	0.0002	0.00193	CcSEcCtD
Isoprenaline—Asthenia—Prednisone—psoriasis	0.000199	0.00192	CcSEcCtD
Isoprenaline—Nausea—Dexamethasone—psoriasis	0.00019	0.00183	CcSEcCtD
Isoprenaline—Nausea—Betamethasone—psoriasis	0.00019	0.00183	CcSEcCtD
Isoprenaline—Dizziness—Prednisone—psoriasis	0.000184	0.00177	CcSEcCtD
Isoprenaline—Headache—Prednisone—psoriasis	0.000174	0.00168	CcSEcCtD
Isoprenaline—Asthenia—Methotrexate—psoriasis	0.000167	0.0016	CcSEcCtD
Isoprenaline—Nausea—Prednisone—psoriasis	0.000165	0.00159	CcSEcCtD
Isoprenaline—Dizziness—Methotrexate—psoriasis	0.000154	0.00148	CcSEcCtD
Isoprenaline—Headache—Methotrexate—psoriasis	0.000145	0.0014	CcSEcCtD
Isoprenaline—Nausea—Methotrexate—psoriasis	0.000138	0.00133	CcSEcCtD
Isoprenaline—PIK3R3—Disease—TYK2—psoriasis	4.31e-05	0.000121	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—NFKBIA—psoriasis	4.29e-05	0.00012	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CCL20—psoriasis	4.27e-05	0.00012	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—SOCS1—psoriasis	4.27e-05	0.00012	CbGpPWpGaD
Isoprenaline—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	4.26e-05	0.000119	CbGpPWpGaD
Isoprenaline—MAPK1—Cellular Senescence—IL6—psoriasis	4.25e-05	0.000119	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—HLA-A—psoriasis	4.23e-05	0.000119	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—CD4—psoriasis	4.22e-05	0.000118	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—SOCS1—psoriasis	4.2e-05	0.000118	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—NOS2—psoriasis	4.19e-05	0.000118	CbGpPWpGaD
Isoprenaline—PIK3R1—Innate Immune System—JUN—psoriasis	4.19e-05	0.000117	CbGpPWpGaD
Isoprenaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	4.16e-05	0.000117	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—NOS2—psoriasis	4.13e-05	0.000116	CbGpPWpGaD
Isoprenaline—PIK3R3—Metabolism—PPARG—psoriasis	4.12e-05	0.000115	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by GPCR—TYK2—psoriasis	4.07e-05	0.000114	CbGpPWpGaD
Isoprenaline—PIK3R1—Hemostasis—VEGFA—psoriasis	4.06e-05	0.000114	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—CRP—psoriasis	4.03e-05	0.000113	CbGpPWpGaD
Isoprenaline—PIK3R1—Innate Immune System—NFKB1—psoriasis	4.03e-05	0.000113	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by GPCR—TYK2—psoriasis	4.01e-05	0.000112	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—TYK2—psoriasis	3.98e-05	0.000112	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—LEP—psoriasis	3.95e-05	0.000111	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—APOE—psoriasis	3.95e-05	0.000111	CbGpPWpGaD
Isoprenaline—MAPK1—Axon guidance—VEGFA—psoriasis	3.94e-05	0.000111	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—CAT—psoriasis	3.93e-05	0.00011	CbGpPWpGaD
Isoprenaline—MAPK1—NGF signalling via TRKA from the plasma membrane—IL6—psoriasis	3.92e-05	0.00011	CbGpPWpGaD
Isoprenaline—PIK3R3—Innate Immune System—IL6—psoriasis	3.92e-05	0.00011	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—HLA-A—psoriasis	3.9e-05	0.000109	CbGpPWpGaD
Isoprenaline—PIK3R2—GPCR downstream signaling—CXCL8—psoriasis	3.9e-05	0.000109	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—CD4—psoriasis	3.89e-05	0.000109	CbGpPWpGaD
Isoprenaline—PIK3R1—Adaptive Immune System—NFKB1—psoriasis	3.87e-05	0.000108	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—HLA-DRB1—psoriasis	3.86e-05	0.000108	CbGpPWpGaD
Isoprenaline—ADRBK1—GPCR downstream signaling—CXCL8—psoriasis	3.84e-05	0.000108	CbGpPWpGaD
Isoprenaline—PIK3R2—Hemostasis—TP53—psoriasis	3.79e-05	0.000106	CbGpPWpGaD
Isoprenaline—MAPK1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	3.79e-05	0.000106	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—JUN—psoriasis	3.78e-05	0.000106	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism—APOE—psoriasis	3.77e-05	0.000106	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—TYK2—psoriasis	3.72e-05	0.000104	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—ICAM1—psoriasis	3.71e-05	0.000104	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—NFKBIA—psoriasis	3.68e-05	0.000103	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—NFKBIA—psoriasis	3.68e-05	0.000103	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—TYK2—psoriasis	3.66e-05	0.000103	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—APOE—psoriasis	3.64e-05	0.000102	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CCL20—psoriasis	3.64e-05	0.000102	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—SOCS1—psoriasis	3.64e-05	0.000102	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—NFKB1—psoriasis	3.63e-05	0.000102	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CCL20—psoriasis	3.56e-05	9.98e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by GPCR—CXCL8—psoriasis	3.54e-05	9.93e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—TYK2—psoriasis	3.52e-05	9.86e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Cellular responses to stress—TP53—psoriasis	3.51e-05	9.85e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by GPCR—CXCL8—psoriasis	3.49e-05	9.78e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—IFNG—psoriasis	3.48e-05	9.76e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—SOCS1—psoriasis	3.46e-05	9.7e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—TYK2—psoriasis	3.43e-05	9.62e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—IFNG—psoriasis	3.43e-05	9.61e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—NOS2—psoriasis	3.4e-05	9.52e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—TYK2—psoriasis	3.38e-05	9.48e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—SOCS1—psoriasis	3.37e-05	9.46e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—CD4—psoriasis	3.36e-05	9.43e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—CD4—psoriasis	3.31e-05	9.29e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—TYK2—psoriasis	3.3e-05	9.24e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism—PPARG—psoriasis	3.28e-05	9.2e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—STAT3—psoriasis	3.27e-05	9.16e-05	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR ligand binding—CXCL8—psoriasis	3.24e-05	9.09e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—CD8A—psoriasis	3.22e-05	9.04e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—TYK2—psoriasis	3.22e-05	9.02e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Cellular responses to stress—IL6—psoriasis	3.21e-05	9.01e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—CD4—psoriasis	3.18e-05	8.91e-05	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR ligand binding—CXCL8—psoriasis	3.17e-05	8.89e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—GPCR downstream signaling—CXCL8—psoriasis	3.16e-05	8.86e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—LEP—psoriasis	3.15e-05	8.83e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—APOE—psoriasis	3.15e-05	8.83e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Innate Immune System—IL6—psoriasis	3.12e-05	8.75e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—CD4—psoriasis	3.1e-05	8.7e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—LEP—psoriasis	3.1e-05	8.7e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—APOE—psoriasis	3.1e-05	8.7e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—NFKB1—psoriasis	3.1e-05	8.7e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—HLA-B—psoriasis	3.1e-05	8.7e-05	CbGpPWpGaD
Isoprenaline—ADRB3—GPCR downstream signaling—CXCL8—psoriasis	3.09e-05	8.65e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Innate Immune System—IL6—psoriasis	3.08e-05	8.62e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Hemostasis—TP53—psoriasis	3.07e-05	8.61e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Cytokine Signaling in Immune system—IL6—psoriasis	3.07e-05	8.6e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—CD4—psoriasis	3.06e-05	8.57e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—APOE—psoriasis	3.05e-05	8.56e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—TYK2—psoriasis	3.02e-05	8.46e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—STAT3—psoriasis	3.02e-05	8.45e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by NGF—IL6—psoriasis	3.01e-05	8.45e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—TYK2—psoriasis	3.01e-05	8.45e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—JUN—psoriasis	3.01e-05	8.44e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—JUN—psoriasis	2.96e-05	8.31e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—NFKBIA—psoriasis	2.93e-05	8.23e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—NFKB1—psoriasis	2.9e-05	8.12e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—NFKBIA—psoriasis	2.89e-05	8.11e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—HLA-A—psoriasis	2.87e-05	8.06e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—CXCL8—psoriasis	2.87e-05	8.05e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—NFKB1—psoriasis	2.85e-05	8e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—JUN—psoriasis	2.85e-05	7.98e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—IFNG—psoriasis	2.82e-05	7.91e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—VEGFA—psoriasis	2.81e-05	7.89e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—CXCL8—psoriasis	2.8e-05	7.86e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—STAT3—psoriasis	2.79e-05	7.82e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—TYK2—psoriasis	2.78e-05	7.8e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Hemostasis—VEGFA—psoriasis	2.76e-05	7.74e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—CRP—psoriasis	2.74e-05	7.69e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—NFKB1—psoriasis	2.74e-05	7.68e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Axon guidance—IL6—psoriasis	2.73e-05	7.65e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—CD4—psoriasis	2.72e-05	7.64e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—PPARG—psoriasis	2.66e-05	7.45e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—HLA-A—psoriasis	2.65e-05	7.44e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—CXCL8—psoriasis	2.63e-05	7.36e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—HLA-DRB1—psoriasis	2.63e-05	7.36e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—STAT3—psoriasis	2.6e-05	7.3e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.58e-05	7.24e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—STAT3—psoriasis	2.56e-05	7.19e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—LEP—psoriasis	2.55e-05	7.15e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—APOE—psoriasis	2.55e-05	7.15e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Innate Immune System—IL6—psoriasis	2.53e-05	7.09e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—ICAM1—psoriasis	2.52e-05	7.07e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—CD4—psoriasis	2.52e-05	7.05e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—NFKBIA—psoriasis	2.5e-05	7.01e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling by GPCR—IL6—psoriasis	2.5e-05	7e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—LEP—psoriasis	2.49e-05	6.98e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—APOE—psoriasis	2.49e-05	6.98e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—APOE—psoriasis	2.48e-05	6.94e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—JUN—psoriasis	2.44e-05	6.84e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—JUN—psoriasis	2.44e-05	6.84e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—TNF—psoriasis	2.41e-05	6.76e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—CARM1—psoriasis	2.41e-05	6.75e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—TYK2—psoriasis	2.4e-05	6.74e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—STAT3—psoriasis	2.4e-05	6.74e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—NFKBIA—psoriasis	2.38e-05	6.67e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—TYK2—psoriasis	2.37e-05	6.64e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—STAT3—psoriasis	2.37e-05	6.64e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—SOCS1—psoriasis	2.35e-05	6.59e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—NFKB1—psoriasis	2.35e-05	6.59e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—NFKB1—psoriasis	2.35e-05	6.58e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—NFKBIA—psoriasis	2.32e-05	6.51e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—NOS2—psoriasis	2.31e-05	6.47e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—IL6—psoriasis	2.28e-05	6.4e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.25e-05	6.31e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—TYK2—psoriasis	2.24e-05	6.28e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—VEGFA—psoriasis	2.13e-05	5.98e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—STAT3—psoriasis	2.11e-05	5.92e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—STAT3—psoriasis	2.11e-05	5.91e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—IL6—psoriasis	2.11e-05	5.91e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—CXCL8—psoriasis	2.09e-05	5.87e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Hemostasis—TP53—psoriasis	2.09e-05	5.85e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—CXCL8—psoriasis	2.06e-05	5.78e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—TYK2—psoriasis	2.05e-05	5.74e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—SOCS1—psoriasis	2e-05	5.62e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by GPCR—IL6—psoriasis	1.99e-05	5.58e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Cell Cycle—TP53—psoriasis	1.97e-05	5.52e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by GPCR—IL6—psoriasis	1.96e-05	5.5e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—SOCS1—psoriasis	1.96e-05	5.49e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—CXCL8—psoriasis	1.95e-05	5.47e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—TYK2—psoriasis	1.95e-05	5.46e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—STAT3—psoriasis	1.95e-05	5.46e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—IL6—psoriasis	1.95e-05	5.46e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—JUN—psoriasis	1.95e-05	5.46e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—IFNG—psoriasis	1.92e-05	5.38e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—JUN—psoriasis	1.92e-05	5.37e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—TYK2—psoriasis	1.91e-05	5.36e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—TYK2—psoriasis	1.9e-05	5.33e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—TYK2—psoriasis	1.89e-05	5.3e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—NFKB1—psoriasis	1.87e-05	5.25e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—TYK2—psoriasis	1.87e-05	5.24e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—CD4—psoriasis	1.85e-05	5.19e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—NFKB1—psoriasis	1.84e-05	5.17e-05	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—CXCL8—psoriasis	1.83e-05	5.13e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—IL6—psoriasis	1.82e-05	5.1e-05	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—CXCL8—psoriasis	1.79e-05	5.02e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—IL6—psoriasis	1.79e-05	5.02e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—APOE—psoriasis	1.73e-05	4.86e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—LEP—psoriasis	1.73e-05	4.86e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—IL6—psoriasis	1.72e-05	4.82e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—CD4—psoriasis	1.71e-05	4.79e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—VEGFA—psoriasis	1.7e-05	4.77e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—CXCL8—psoriasis	1.7e-05	4.75e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—STAT3—psoriasis	1.68e-05	4.72e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—IL6—psoriasis	1.68e-05	4.71e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—VEGFA—psoriasis	1.67e-05	4.69e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—CXCL8—psoriasis	1.66e-05	4.66e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—STAT3—psoriasis	1.66e-05	4.65e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—JUN—psoriasis	1.66e-05	4.65e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—CXCL8—psoriasis	1.66e-05	4.64e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—IL6—psoriasis	1.65e-05	4.64e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—CXCL8—psoriasis	1.63e-05	4.56e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—NFKBIA—psoriasis	1.62e-05	4.53e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—IL6—psoriasis	1.61e-05	4.52e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—TP53—psoriasis	1.61e-05	4.52e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—NFKB1—psoriasis	1.6e-05	4.47e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—JUN—psoriasis	1.58e-05	4.42e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—IL6—psoriasis	1.57e-05	4.41e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—JUN—psoriasis	1.54e-05	4.31e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—NFKB1—psoriasis	1.52e-05	4.25e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—NFKB1—psoriasis	1.48e-05	4.15e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—CAT—psoriasis	1.48e-05	4.15e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—LEP—psoriasis	1.48e-05	4.14e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—APOE—psoriasis	1.48e-05	4.14e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—IL6—psoriasis	1.47e-05	4.14e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—IL6—psoriasis	1.47e-05	4.13e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—APOE—psoriasis	1.45e-05	4.05e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—LEP—psoriasis	1.45e-05	4.05e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—STAT3—psoriasis	1.43e-05	4.02e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—NFKBIA—psoriasis	1.38e-05	3.86e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—VEGFA—psoriasis	1.38e-05	3.86e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—STAT3—psoriasis	1.36e-05	3.82e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—IL6—psoriasis	1.36e-05	3.81e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—NFKBIA—psoriasis	1.35e-05	3.78e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—VEGFA—psoriasis	1.34e-05	3.77e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—STAT3—psoriasis	1.33e-05	3.73e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—TYK2—psoriasis	1.32e-05	3.71e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—STAT3—psoriasis	1.32e-05	3.71e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—TP53—psoriasis	1.28e-05	3.6e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—TP53—psoriasis	1.27e-05	3.55e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—IL6—psoriasis	1.18e-05	3.3e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—IL6—psoriasis	1.16e-05	3.25e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CXCL8—psoriasis	1.15e-05	3.23e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—APOE—psoriasis	1.15e-05	3.23e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—TYK2—psoriasis	1.13e-05	3.16e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—TYK2—psoriasis	1.1e-05	3.09e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—IL6—psoriasis	1.1e-05	3.07e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—JUN—psoriasis	1.07e-05	3e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—TP53—psoriasis	1.04e-05	2.92e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—NFKB1—psoriasis	1.03e-05	2.89e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—TP53—psoriasis	1.02e-05	2.85e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—PPARG—psoriasis	1e-05	2.81e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—IL6—psoriasis	1e-05	2.81e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CXCL8—psoriasis	9.82e-06	2.75e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CXCL8—psoriasis	9.61e-06	2.69e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—IL6—psoriasis	9.53e-06	2.67e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—VEGFA—psoriasis	9.36e-06	2.62e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—IL6—psoriasis	9.34e-06	2.62e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—IL6—psoriasis	9.3e-06	2.61e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—STAT3—psoriasis	9.27e-06	2.6e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—IL6—psoriasis	9.25e-06	2.59e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—IL6—psoriasis	9.14e-06	2.56e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—JUN—psoriasis	9.13e-06	2.56e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—JUN—psoriasis	8.93e-06	2.5e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—NFKB1—psoriasis	8.79e-06	2.46e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—NFKB1—psoriasis	8.6e-06	2.41e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—VEGFA—psoriasis	7.98e-06	2.24e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—STAT3—psoriasis	7.9e-06	2.22e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—VEGFA—psoriasis	7.8e-06	2.19e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—STAT3—psoriasis	7.73e-06	2.17e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—TP53—psoriasis	7.07e-06	1.98e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—IL6—psoriasis	6.47e-06	1.82e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—TP53—psoriasis	6.03e-06	1.69e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—TP53—psoriasis	5.9e-06	1.65e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—IL6—psoriasis	5.52e-06	1.55e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—IL6—psoriasis	5.4e-06	1.51e-05	CbGpPWpGaD
